Evaluation of the QuantiFERON-TB Test.
NCT02256839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 268
Last updated 2019-08-01
Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Conditions
Interventions
- DEVICE
-
CST_001
Sponsors & Collaborators
-
QIAGEN Gaithersburg, Inc
lead INDUSTRY
Principal Investigators
-
Kevin Winthrop, MD, M.P.H · Oregon Health and Science University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
NCT02119130 ·Status: COMPLETED ·Phase: NA
-
The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis
NCT00982969 ·Status: COMPLETED
-
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
NCT01223534 ·Status: COMPLETED ·Phase: PHASE4
-
QuantiFERON Access Clinical Performance Study Protocol
NCT04243031 ·Status: WITHDRAWN
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
NCT01642888 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
NCT00402402 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
NCT00424684 ·Status: WITHDRAWN ·Phase: NA
-
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
NCT00491933 ·Status: UNKNOWN ·Phase: NA
-
QuantiFERON Change During Anti-tuberculosis Medication
NCT01038830 ·Status: COMPLETED
-
Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers
NCT00797836 ·Status: COMPLETED ·Phase: PHASE4
-
Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers
NCT01376843 ·Status: COMPLETED
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Self-Assessment Tuberculin Skin Test
NCT03835832 ·Status: COMPLETED
-
Evaluating the Accuracy of New Tests for TB Infection Diagnosis
NCT06221735 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198 ·Status: COMPLETED
-
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
NCT02512939 ·Status: COMPLETED ·Phase: NA
-
Latent Tuberculosis Infection in Bone Marrow Transplant Recipients
NCT01021124 ·Status: COMPLETED
-
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
NCT06019052 ·Status: NOT_YET_RECRUITING
-
T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals
NCT00707317 ·Status: COMPLETED
-
Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
NCT01223976 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
NCT00811343 ·Status: COMPLETED ·Phase: NA
-
Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB
NCT06392594 ·Status: NOT_YET_RECRUITING
-
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
NCT04752592 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED